3.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.56
Aprire:
$3.49
Volume 24 ore:
77,702
Relative Volume:
1.15
Capitalizzazione di mercato:
$50.27M
Reddito:
$37.79M
Utile/perdita netta:
$-10.38M
Rapporto P/E:
-4.6027
EPS:
-0.73
Flusso di cassa netto:
$-1.00M
1 W Prestazione:
-9.43%
1M Prestazione:
+1.82%
6M Prestazione:
+29.73%
1 anno Prestazione:
+125.50%
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Nome
Cumberland Pharmaceuticals Inc
Settore
Telefono
615-255-0068
Indirizzo
2525 WEST END AVENUE, NASHVILLE,, TN
Confronta CPIX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CPIX
Cumberland Pharmaceuticals Inc
|
3.36 | 53.26M | 37.79M | -10.38M | -1.00M | -0.73 |
![]()
ZTS
Zoetis Inc
|
152.82 | 68.32B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.66 | 46.55B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
HLN
Haleon Plc Adr
|
9.85 | 43.80B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.33 | 19.01B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
306.41 | 13.79B | 2.99B | 1.21B | 1.13B | 25.06 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2012-11-12 | Reiterato | UBS | Neutral |
2011-02-01 | Reiterato | UBS | Neutral |
2010-12-16 | Downgrade | UBS | Buy → Neutral |
2010-08-17 | Downgrade | Jefferies | Buy → Hold |
2010-08-17 | Reiterato | Morgan Joseph | Buy |
2010-08-17 | Reiterato | UBS | Buy |
2010-05-14 | Reiterato | Morgan Joseph | Buy |
Mostra tutto
Cumberland Pharmaceuticals Inc Borsa (CPIX) Ultime notizie
What drives Cumberland Pharmaceuticals Inc. stock priceAccelerated wealth building - Autocar Professional
Is Cumberland Pharmaceuticals Inc. a good long term investmentAccelerated wealth expansion - Autocar Professional
Cumberland Pharmaceuticals Inc. Stock Analysis and ForecastTremendous portfolio expansion - jammulinksnews.com
What analysts say about Cumberland Pharmaceuticals Inc. stockBreakthrough investment results - Autocar Professional
how cumberland pharmaceuticals inc. stock performs during market volatilityFree Elite Traders Group - Newser
Is Cumberland Pharmaceuticals Inc. stock a growth or value playSmart Money Trade Setups - Newser
Why Cumberland Pharmaceuticals Inc. stock attracts strong analyst attentionROI Driven Alerts - Newser
How Cumberland Pharmaceuticals Inc. stock performs during market volatilityBest Stocks for Capital Safety - Newser
What makes Cumberland Pharmaceuticals Inc. stock price move sharplyChart Breakout Alert - Newser
Caroline Young of Cumberland Pharmaceuticals buys CPIX shares By Investing.com - Investing.com Nigeria
Caroline Young of Cumberland Pharmaceuticals buys CPIX shares - Investing.com Australia
Cumberland Pharma CEO A J Kazimi buys shares worth $807 - Investing.com Australia
Cumberland Pharma CEO A J Kazimi buys shares worth $807 By Investing.com - Investing.com Canada
Cumberland Pharmaceuticals Advances Ifetroban Study for SSc and SSc-PAH - The Globe and Mail
Cumberland Pharmaceuticals Inc.(NasdaqGS:CPIX) added to Russell Microcap Growth Index - MarketScreener
Cumberland reports positive DMD heart drug trial results - Investing.com
Asthma Market to Expand Significantly by 2034, States - openPR.com
Asthma Market to Expand Significantly by 2034, States DelveInsight Report | GSK, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma, Genentech - Barchart.com
Two Sigma Investments LP Has $89,000 Stake in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) - Defense World
Cumberland Pharmaceuticals Inc Azioni (CPIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):